Morten H Møller1, Waleed Alhazzani2,3, Kimberley Lewis2, Emilie Belley-Cote4, Anders Granholm5, John Centofanti6, William B McIntyre7,8, Jessica Spence3,9, Zainab Al Duhailib10, Dale M Needham11, Laura Evans12, Annika Reintam Blaser13,14, Margaret A Pisani15, Frederick D'Aragon16,17, Manu Shankar-Hari18, Mohammed Alshahrani19, Giuseppe Citerio20, Rakesh C Arora21, Sangeeta Mehta22, Timothy D Girard23, Otavio T Ranzani24,25, Naomi Hammond26,27, John W Devlin28,29, Yahya Shehabi30,31, Pratik Pandharipande32, Marlies Ostermann33. 1. Department of Intensive Care, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. mortenhylander@gmail.com. 2. Division of Critical Care, Department of Medicine, McMaster University, Hamilton, Canada. 3. Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada. 4. Divisions of Cardiology and Critical Care, McMaster University, Hamilton, ON, Canada. 5. Department of Intensive Care, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark. 6. Department of Anesthesia, McMaster University, Hamilton, ON, Canada. 7. Population Health Research Institute, Hamilton, ON, Canada. 8. Department of Medicine, McMaster University, Hamilton, ON, Canada. 9. Department of Anesthesia and Critical Care, McMaster University, Hamilton, ON, Canada. 10. Department of Critical Care Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. 11. Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, USA. 12. Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, USA. 13. Department of Anaesthesiology and Intensive Care, University of Tartu, Tartu, Estonia. 14. Department of Intensive Care Medicine, Lucerne Cantonal Hospital, Lucerne, Switzerland. 15. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Yale University School of Medicine, New Haven, CT, 06501, USA. 16. Department of Anesthesiology, Universite de Sherbrooke, Sherbrooke, QC, Canada. 17. Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada. 18. Centre for Inflammation Research, The University of Edinburgh The Queen's Medical Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ, UK. 19. Department of Emergency and Critical Care, College of Medicine, Imam Abdulrahman Ben Faisal University, Dammam, Saudi Arabia. 20. School of Medicine and Surgery, University Milano-Bicocca; Neurorianimazione, ASST-Monza, Monza, Italy. 21. Department of Surgery, Section of Cardiac Surgery, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB, Canada. 22. Department of Medicine, Sinai Health, and Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada. 23. Department of Critical Care Medicine, Clinical Research, Investigation, and Systems Modeling of Acute Illness (CRISMA) Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 24. Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain. 25. Pulmonary Division, Heart Institute, Hospital das Clínicas, Faculdade de Medicina, São Paulo, SP, Brazil. 26. Critical Care Program, The George Institute for Global Health and UNSW Sydney, Newtown, NSW, Australia. 27. Malcolm Fisher Department of Intensive Care, Royal North Shore Hospital, St Leonards, NSW, Australia. 28. Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA, USA. 29. School of Pharmacy, Northeastern University, Boston, MA, USA. 30. Department of Intensive Care, Monash Health School of Clinical Sciences, Monash University, Clayton, VIC, 3168, Australia. 31. School of Clinical Medicine, University of New South Wales, Sydney, NSW, 2031, Australia. 32. Division of Anesthesiology Critical Care Medicine, Department of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA. 33. Department of Critical Care, King's College London, Guy's & St Thomas' Hospital, London, UK.
Abstract
PURPOSE: The aim of this Intensive Care Medicine Rapid Practice Guideline (ICM‑RPG) was to formulate evidence‑based guidance for the use of dexmedetomidine for sedation in invasively mechanically ventilated adults in the intensive care unit (ICU). METHODS: We adhered to the methodology for trustworthy clinical practice guidelines, including use of the Grading of Recommendations Assessment, Development, and Evaluation approach to assess the certainty of evidence, and the Evidence-to-Decision framework to generate recommendations. The guideline panel comprised 28 international panelists, including content experts, ICU clinicians, methodologists, and patient representatives. Through teleconferences and web‑based discussions, the panel provided input on the balance and magnitude of the desirable and undesirable effects, the certainty of evidence, patients' values and preferences, costs and resources, feasibility, acceptability, and research priorities. RESULTS: The ICM‑RPG panel issued one weak recommendation (suggestion) based on overall moderate certainty of evidence: "In invasively mechanically ventilated adult ICU patients, we suggest using dexmedetomidine over other sedative agents, if the desirable effects including a reduction in delirium are valued over the undesirable effects including an increase in hypotension and bradycardia". CONCLUSION: This ICM-RPG provides updated evidence-based guidance on the use of dexmedetomidine for sedation in mechanically ventilated adults, and outlines uncertainties and research priorities.
PURPOSE: The aim of this Intensive Care Medicine Rapid Practice Guideline (ICM‑RPG) was to formulate evidence‑based guidance for the use of dexmedetomidine for sedation in invasively mechanically ventilated adults in the intensive care unit (ICU). METHODS: We adhered to the methodology for trustworthy clinical practice guidelines, including use of the Grading of Recommendations Assessment, Development, and Evaluation approach to assess the certainty of evidence, and the Evidence-to-Decision framework to generate recommendations. The guideline panel comprised 28 international panelists, including content experts, ICU clinicians, methodologists, and patient representatives. Through teleconferences and web‑based discussions, the panel provided input on the balance and magnitude of the desirable and undesirable effects, the certainty of evidence, patients' values and preferences, costs and resources, feasibility, acceptability, and research priorities. RESULTS: The ICM‑RPG panel issued one weak recommendation (suggestion) based on overall moderate certainty of evidence: "In invasively mechanically ventilated adult ICU patients, we suggest using dexmedetomidine over other sedative agents, if the desirable effects including a reduction in delirium are valued over the undesirable effects including an increase in hypotension and bradycardia". CONCLUSION: This ICM-RPG provides updated evidence-based guidance on the use of dexmedetomidine for sedation in mechanically ventilated adults, and outlines uncertainties and research priorities.
Authors: John W Devlin; Yoanna Skrobik; Céline Gélinas; Dale M Needham; Arjen J C Slooter; Pratik P Pandharipande; Paula L Watson; Gerald L Weinhouse; Mark E Nunnally; Bram Rochwerg; Michele C Balas; Mark van den Boogaard; Karen J Bosma; Nathaniel E Brummel; Gerald Chanques; Linda Denehy; Xavier Drouot; Gilles L Fraser; Jocelyn E Harris; Aaron M Joffe; Michelle E Kho; John P Kress; Julie A Lanphere; Sharon McKinley; Karin J Neufeld; Margaret A Pisani; Jean-Francois Payen; Brenda T Pun; Kathleen A Puntillo; Richard R Riker; Bryce R H Robinson; Yahya Shehabi; Paul M Szumita; Chris Winkelman; John E Centofanti; Carrie Price; Sina Nikayin; Cheryl J Misak; Pamela D Flood; Ken Kiedrowski; Waleed Alhazzani Journal: Crit Care Med Date: 2018-09 Impact factor: 7.598
Authors: Yahya Shehabi; Belinda D Howe; Rinaldo Bellomo; Yaseen M Arabi; Michael Bailey; Frances E Bass; Suhaini Bin Kadiman; Colin J McArthur; Lynnette Murray; Michael C Reade; Ian M Seppelt; Jukka Takala; Matt P Wise; Steven A Webb Journal: N Engl J Med Date: 2019-05-19 Impact factor: 91.245
Authors: Stephan M Jakob; Esko Ruokonen; R Michael Grounds; Toni Sarapohja; Chris Garratt; Stuart J Pocock; J Raymond Bratty; Jukka Takala Journal: JAMA Date: 2012-03-21 Impact factor: 56.272
Authors: Christopher G Hughes; Patrick T Mailloux; John W Devlin; Joshua T Swan; Robert D Sanders; Antonio Anzueto; James C Jackson; Aimee S Hoskins; Brenda T Pun; Onur M Orun; Rameela Raman; Joanna L Stollings; Amy L Kiehl; Matthew S Duprey; Lan N Bui; Hollis R O'Neal; Allison Snyder; Michael A Gropper; Kalpalatha K Guntupalli; Gregg J Stashenko; Mayur B Patel; Nathan E Brummel; Timothy D Girard; Robert S Dittus; Gordon R Bernard; E Wesley Ely; Pratik P Pandharipande Journal: N Engl J Med Date: 2021-02-02 Impact factor: 91.245
Authors: Richard R Riker; Yahya Shehabi; Paula M Bokesch; Daniel Ceraso; Wayne Wisemandle; Firas Koura; Patrick Whitten; Benjamin D Margolis; Daniel W Byrne; E Wesley Ely; Marcelo G Rocha Journal: JAMA Date: 2009-02-02 Impact factor: 56.272
Authors: Simon J Erickson; Johnny Millar; Brian J Anderson; Marino S Festa; Lahn Straney; Yahya Shehabi; Debbie A Long Journal: Pediatr Crit Care Med Date: 2020-09 Impact factor: 3.624
Authors: Matthew S Duprey; Sandra M A Dijkstra-Kersten; Irene J Zaal; Becky A Briesacher; Jane S Saczynski; John L Griffith; John W Devlin; Arjen J C Slooter Journal: Am J Respir Crit Care Med Date: 2021-09-01 Impact factor: 30.528
Authors: Maud A S Weerink; Michel M R F Struys; Laura N Hannivoort; Clemens R M Barends; Anthony R Absalom; Pieter Colin Journal: Clin Pharmacokinet Date: 2017-08 Impact factor: 6.447